Open access
Oct 2026
ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202.
Traditional weight-based dosing results in variable rabbit anti-thymocyte globulin (rATG) clearance, delaying CD4+Tcell-immune-reconstitution (CD4 + IR) and impacting outcomes. In a retrospective pharmacokinetic/pharmacodynamic analysis of patients undergoing first T-replete hematopoietic cell transplantation (HCT), en...
M. Lakkaraja, A. Mauguen, K. Hosszu et al.
· Bone Marrow Transplantation · 0 citations